185 related articles for article (PubMed ID: 26066011)
1. Designing Normative Messages About Active Surveillance for Men With Localized Prostate Cancer.
Volk RJ; Kinsman GT; Le YC; Swank P; Blumenthal-Barby J; McFall SL; Byrd TL; Mullen PD; Cantor SB
J Health Commun; 2015; 20(9):1014-20. PubMed ID: 26066011
[TBL] [Abstract][Full Text] [Related]
2. Active surveillance for low-risk localized prostate cancer: what do men and their partners think?
Mallapareddi A; Ruterbusch J; Reamer E; Eggly S; Xu J
Fam Pract; 2017 Feb; 34(1):90-97. PubMed ID: 28034917
[TBL] [Abstract][Full Text] [Related]
3. 'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option.
O'Callaghan C; Dryden T; Hyatt A; Brooker J; Burney S; Wootten AC; White A; Frydenberg M; Murphy D; Williams S; Schofield P
Psychooncology; 2014 Dec; 23(12):1391-8. PubMed ID: 24830805
[TBL] [Abstract][Full Text] [Related]
4. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance.
Pickles T; Ruether JD; Weir L; Carlson L; Jakulj F;
BJU Int; 2007 Sep; 100(3):544-51. PubMed ID: 17532857
[TBL] [Abstract][Full Text] [Related]
6. Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
Davison BJ; Goldenberg SL
BJU Int; 2011 Dec; 108(11):1787-93. PubMed ID: 21507187
[TBL] [Abstract][Full Text] [Related]
7. Population-based assessment of determining predictors for quality of prostate cancer surveillance.
Chamie K; Williams SB; Hershman DL; Wright JD; Nguyen PL; Hu JC
Cancer; 2015 Dec; 121(23):4150-7. PubMed ID: 26307939
[TBL] [Abstract][Full Text] [Related]
8. Patient and disease factors affecting the choice and adherence to active surveillance.
Dall'Era MA
Curr Opin Urol; 2015 May; 25(3):272-6. PubMed ID: 25692724
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer.
Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ
BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973
[TBL] [Abstract][Full Text] [Related]
10. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
Davison BJ; Oliffe JL; Pickles T; Mroz L
Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
[TBL] [Abstract][Full Text] [Related]
11. Population based study of use and determinants of active surveillance and watchful waiting for low and intermediate risk prostate cancer.
Loeb S; Berglund A; Stattin P
J Urol; 2013 Nov; 190(5):1742-9. PubMed ID: 23727309
[TBL] [Abstract][Full Text] [Related]
12. Predictors of pathological progression among men with localized prostate cancer undergoing active surveillance: a sub-analysis of the REDEEM study.
Margel D; Nandy I; Wilson TH; Castro R; Fleshner N
J Urol; 2013 Dec; 190(6):2039-45. PubMed ID: 23820059
[TBL] [Abstract][Full Text] [Related]
13. Predictors of pathologic progression on biopsy among men on active surveillance for localized prostate cancer: the value of the pattern of surveillance biopsies.
Cary KC; Cowan JE; Sanford M; Shinohara K; Perez N; Chan JM; Meng MV; Carroll PR
Eur Urol; 2014 Aug; 66(2):337-42. PubMed ID: 24035632
[TBL] [Abstract][Full Text] [Related]
14. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
15. Is "Active Surveillance" an Acceptable Alternative?: A Qualitative Study of Couples' Decision Making about Early-Stage, Localized Prostate Cancer.
Le YL; McFall SL; Byrd TL; Volk RJ; Cantor SB; Kuban DA; Mullen PD
Narrat Inq Bioeth; 2016; 6(1):51-61. PubMed ID: 27346824
[TBL] [Abstract][Full Text] [Related]
16. Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
Mader EM; Li HH; Lyons KD; Morley CP; Formica MK; Perrapato SD; Irwin BH; Seigne JD; Hyams ES; Mosher T; Hegel MT; Stewart TM
BMC Urol; 2017 May; 17(1):35. PubMed ID: 28482875
[TBL] [Abstract][Full Text] [Related]
17. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
[TBL] [Abstract][Full Text] [Related]
18. Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer.
Hoffman RM; Lobo T; Van Den Eeden SK; Davis KM; Luta G; Leimpeter AD; Aaronson D; Penson DF; Taylor K
Med Decis Making; 2019 Nov; 39(8):962-974. PubMed ID: 31631745
[No Abstract] [Full Text] [Related]
19. Decision-Making in Prostate Cancer: Active Surveillance Over Other Treatment Options.
Bayliss D; Duff J; Stricker P; Walker K
Urol Nurs; 2016; 36(3):141-9. PubMed ID: 27501595
[TBL] [Abstract][Full Text] [Related]
20. Critical review: is watchful waiting a viable management option for older men with prostate cancer?
Bailey DE; Wallace M
Am J Mens Health; 2007 Mar; 1(1):18-28. PubMed ID: 19482780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
